“Research is the lifeblood of medicine,” said Jeffrey Anderson, MD, associate chief of cardiology and co-director of cardiovascular research of the Intermountain Medical Center Heart Institute. “It drives our progress to better understand, prevent, diagnose, and treat cardiovascular disease as well as to achieve healthier living and lifestyle goals.”
Follow @Intermtnmedctr on Twitter to see what’s happening at #ACC15.
During the three-day scientific session, researchers will interact with colleagues from across the globe, learn about evidence-based research and identify opportunities to collaborate on future studies aimed at improving how heart disease is prevented, diagnosed, and treated.
Since the Intermountain Medical Center Heart Institute is home to the world’s largest cardiovascular DNA database and plasma bank repository, researchers at Intermountain are able to lead groundbreaking studies that are leading to advances in heart care. The sample collection began more than 20 years ago and now houses more than 30,000 samples, which are linked to a patient’s medical record for long-term tracking.
Some of the research being presented by the Intermountain Medical Center Heart Institute at #ACC15 include:
- Antidepressants Linked to Improved Cardiovascular Outcomes
- 9/11 Terrorist Attacks in NYC Impacted the Heart Health of Utah Residents
- New Study Finds Screening Diabetic Patients for Coronary Artery Calcification Improves Diagnosis and Treatment of Heart Disease
“What we do here provides new discoveries that can be used almost immediately,” said Benjamin Horne, PhD, director of cardiovascular and genetic epidemiology at the Intermountain Medical Center Heart Institute. “When community members see we’re learning how to provide better care for them through research, they have a lot of confidence we’ll give them the best possible heart care.”